BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11038064)

  • 1. Evaluation of an intrathecal immune response in amyotrophic lateral sclerosis patients implanted with encapsulated genetically engineered xenogeneic cells.
    Zurn AD; Henry H; Schluep M; Aubert V; Winkel L; Eilers B; Bachmann C; Aebischer P
    Cell Transplant; 2000; 9(4):471-84. PubMed ID: 11038064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients.
    Aebischer P; Schluep M; Déglon N; Joseph JM; Hirt L; Heyd B; Goddard M; Hammang JP; Zurn AD; Kato AC; Regli F; Baetge EE
    Nat Med; 1996 Jun; 2(6):696-9. PubMed ID: 8640564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF.
    Aebischer P; Pochon NA; Heyd B; Deglon N; Joseph JM; Zurn AD; Baetge EE; Hammang JP; Goddard M; Lysaght M; Kaplan F; Kato AC; Schluep M; Hirt L; Regli F; Porchet F; De Tribolet N
    Hum Gene Ther; 1996 May; 7(7):851-60. PubMed ID: 8860837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal ciliary neurotrophic factor delivery for treatment of amyotrophic lateral sclerosis (phase I trial).
    Penn RD; Kroin JS; York MM; Cedarbaum JM
    Neurosurgery; 1997 Jan; 40(1):94-9; discussion 99-100. PubMed ID: 8971830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescue of motoneurons from axotomy-induced cell death by polymer encapsulated cells genetically engineered to release CNTF.
    Tan SA; Déglon N; Zurn AD; Baetge EE; Bamber B; Kato AC; Aebischer P
    Cell Transplant; 1996; 5(5):577-87. PubMed ID: 8889216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF.
    Bachoud-Lévi AC; Déglon N; Nguyen JP; Bloch J; Bourdet C; Winkel L; Rémy P; Goddard M; Lefaucheur JP; Brugières P; Baudic S; Cesaro P; Peschanski M; Aebischer P
    Hum Gene Ther; 2000 Aug; 11(12):1723-9. PubMed ID: 10954906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of amyotrophic lateral sclerosis using a gene therapy approach.
    Aebischer P; Kato AC
    Eur Neurol; 1995; 35(2):65-8. PubMed ID: 7796839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technology evaluation: CRIB (CNTF delivery) CytoTherapeutics Inc.
    Abicht A; Lochmüller H
    Curr Opin Mol Ther; 1999 Oct; 1(5):645-50. PubMed ID: 11249671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer-encapsulated genetically modified cells continue to secrete human nerve growth factor for over one year in rat ventricles: behavioral and anatomical consequences.
    Winn SR; Lindner MD; Lee A; Haggett G; Francis JM; Emerich DF
    Exp Neurol; 1996 Aug; 140(2):126-38. PubMed ID: 8690056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study.
    Bloch J; Bachoud-Lévi AC; Déglon N; Lefaucheur JP; Winkel L; Palfi S; Nguyen JP; Bourdet C; Gaura V; Remy P; Brugières P; Boisse MF; Baudic S; Cesaro P; Hantraye P; Aebischer P; Peschanski M
    Hum Gene Ther; 2004 Oct; 15(10):968-75. PubMed ID: 15585112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum CNTF level in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Eur Cytokine Netw; 2003; 14(3):192-4. PubMed ID: 14656696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts.
    Emerich DF; Plone M; Francis J; Frydel BR; Winn SR; Lindner MD
    Brain Res; 1996 Oct; 736(1-2):99-110. PubMed ID: 8930314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants.
    Sieving PA; Caruso RC; Tao W; Coleman HR; Thompson DJ; Fullmer KR; Bush RA
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3896-901. PubMed ID: 16505355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease.
    Mittoux V; Joseph JM; Conde F; Palfi S; Dautry C; Poyot T; Bloch J; Deglon N; Ouary S; Nimchinsky EA; Brouillet E; Hof PR; Peschanski M; Aebischer P; Hantraye P
    Hum Gene Ther; 2000 May; 11(8):1177-87. PubMed ID: 10834619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa.
    Tao W; Wen R; Goddard MB; Sherman SD; O'Rourke PJ; Stabila PF; Bell WJ; Dean BJ; Kauper KA; Budz VA; Tsiaras WG; Acland GM; Pearce-Kelling S; Laties AM; Aguirre GD
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3292-8. PubMed ID: 12356837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Feasibility of Lin- Cells Administration to ALS Patients: A Novel View on Humoral Factors and miRNA Profiles.
    Sobuś A; Baumert B; Litwińska Z; Gołąb-Janowska M; Stępniewski J; Kotowski M; Pius-Sadowska E; Kawa MP; Gródecka-Szwajkiewicz D; Peregud-Pogorzelski J; Dulak J; Nowacki P; Machaliński B
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29702606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encapsulated xenogeneic cells: delivering CNTF to motor neurons.
    O'Brien C
    Mol Med Today; 1996 Nov; 2(11):448-9. PubMed ID: 8947909
    [No Abstract]   [Full Text] [Related]  

  • 18. Transplantation of encapsulated bovine chromaffin cells in the sheep subarachnoid space: a preclinical study for the treatment of cancer pain.
    Joseph JM; Goddard MB; Mills J; Padrun V; Zurn A; Zielinski B; Favre J; Gardaz JP; Mosimann F; Sagen J
    Cell Transplant; 1994; 3(5):355-64. PubMed ID: 7530113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis.
    Oh KW; Moon C; Kim HY; Oh SI; Park J; Lee JH; Chang IY; Kim KS; Kim SH
    Stem Cells Transl Med; 2015 Jun; 4(6):590-7. PubMed ID: 25934946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts.
    Déglon N; Heyd B; Tan SA; Joseph JM; Zurn AD; Aebischer P
    Hum Gene Ther; 1996 Nov; 7(17):2135-46. PubMed ID: 8934227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.